Updates in The Treatment of Advanced NSCLC with Immune Checkpoint Inhibitors

Drs Peters and Johnson discuss recent updates in the treatment of advanced NSCLC with single- and dual-agent immunotherapy regimens.

Related Videos
View All
Related Content